Director/PDMR Shareholding
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||||
a) | Name | Jim Thompson | ||||||||
2 | Reason for the notification
| |||||||||
a) | Position/status | Person discharging managerial responsibilities (Non-Executive Director) | ||||||||
b) | Initial Notification Amendment | Initial Notification
| ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | C&C Group plc | ||||||||
b) | LEI | 635400LNUHA2LDXXV850 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code | American Depositary Receipts ("ADRs"), each representing three Ordinary Shares of €0.01 each of C&C Group plc
ADR ISIN: US1246511000 | ||||||||
b) | Nature of the transaction | Acquisition of 7,000 ADRs, representing 21,000 Ordinary Shares of C&C Group plc
| ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information - Aggregated volume - Price |
| ||||||||
e) | Date of the transaction | 1. 22 January 2020 2. 23 January 2020 3. 23 January 2020
| ||||||||
f) | Place of the transaction | Outside of a trading venue (OTC) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.